Target Name: CFAP57
NCBI ID: G149465
Review Report on CFAP57 Target / Biomarker Content of Review Report on CFAP57 Target / Biomarker
CFAP57
Other Name(s): Cilia and flagella associated protein 57, transcript variant 3 | cilia and flagella associated protein 57 | VWS2 | OTTHUMP00000008355 | WDR65 | WDR65a | WD repeat domain 65 | Cilia- and flagella-associated protein 57 (isoform a) | WD repeat-containing protein 65 | CFAP57 variant 3 | FLJ32000 | CFAP57 variant 5 | Cilia and flagella associated protein 57, transcript variant 1 | Cilia and flagella associated protein 57, transcript variant 5 | Cilia- and flagella-associated protein 57 (isoform 1) | CFAP57 variant 1 | Cilia- and flagella-associated protein 57 | CFA57_HUMAN

Cilia and flagella associated protein 57 (CFAP57): A Potential Drug Target and Biomarker

Cilia and flagella associated protein 57 (CFAP57) is a protein that plays a critical role in the function of cilia, which are tiny hair-like structures that line the surface of various body cells. Cilia are responsible for moving fluids and particles across the surface of the body, and their movement is essential for various physiological processes, including the delivery of nutrients, medications, and waste products. CFAP57 is a protein that is expressed in high levels in the cilia, and its function is essential for the proper functioning of cilia.

The drug target

CFAP57 has been identified as a potential drug target for various diseases, including cancer, neurodegenerative diseases, and respiratory disorders. Its function in the regulation of cilia movement makes it an attractive target for drugs that are designed to modulate cilia function.

One of the key features of CFAP57 is its role in the regulation of cilia movement. Cilia movement is regulated by a complex system that includes multiple proteins, including CFAP57. CFAP57 plays a critical role in the regulation of cilia movement by interacting with other proteins, including the flagellin protein.

The neurodegenerative diseases

CFAP57 has also been identified as a potential biomarker for neurodegenerative diseases. As neurodegenerative diseases progress, the function of cilia is often compromised, leading to the build-up of waste products and the disruption of normal cellular processes. CFAP57 has been shown to be expressed in the brains of individuals with neurodegenerative diseases, and its levels have been associated with the severity of the disease.

The role of CFAP57 in cancer

CFAP57 has also been shown to be involved in the regulation of cancer cell growth and the development of cancer. It has been shown to play a critical role in the regulation of cell division and the production of new blood vessels, which are critical for the growth and spread of cancer cells.

The respiratory disorders

CFAP57 has also been identified as a potential drug target for respiratory disorders. As individuals with respiratory disorders, the function of cilia is often compromised, leading to the build-up of waste products and the disruption of normal cellular processes. CFAP57 has been shown to play a critical role in the regulation of cilia movement in the lungs, and its levels have been associated with the severity of respiratory disorders.

Conclusion

CFAP57 is a protein that has been identified as a potential drug target for various diseases, including cancer, neurodegenerative diseases, and respiratory disorders. Its function in the regulation of cilia movement makes it an attractive target for drugs that are designed to modulate cilia function. Further research is needed to fully understand the role of CFAP57 in various diseases and to develop effective treatments.

Protein Name: Cilia And Flagella Associated Protein 57

The "CFAP57 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CFAP57 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

CFAP58 | CFAP61 | CFAP65 | CFAP68 | CFAP69 | CFAP70 | CFAP73 | CFAP74 | CFAP77 | CFAP90 | CFAP91 | CFAP92 | CFAP95 | CFAP95-DT | CFAP97 | CFAP97D1 | CFAP99 | CFB | CFC1 | CFD | CFDP1 | CFH | CFHR1 | CFHR2 | CFHR3 | CFHR4 | CFHR5 | CFI | CFL1 | CFL1P1 | CFL1P2 | CFL1P3 | CFL1P4 | CFL1P5 | CFL2 | CFLAR | CFLAR-AS1 | CFP | CFTR | CGA | CGAS | CGB1 | CGB2 | CGB3 | CGB5 | CGB7 | CGB8 | CGGBP1 | cGMP Phosphdiesterase (PDE) | cGMP-Dependent Protein Kinase | CGN | CGNL1 | CGREF1 | CGRRF1 | CH25H | CHAC1 | CHAC2 | CHAD | CHADL | CHAF1A | CHAF1B | CHAMP1 | Chaperone | Chaperonin-containing T-complex polypeptde 1 complex (CCT) | CHASERR | CHAT | CHCHD1 | CHCHD10 | CHCHD2 | CHCHD2P6 | CHCHD2P9 | CHCHD3 | CHCHD4 | CHCHD5 | CHCHD6 | CHCHD7 | CHCT1 | CHD1 | CHD1-DT | CHD1L | CHD2 | CHD3 | CHD4 | CHD5 | CHD6 | CHD7 | CHD8 | CHD9 | CHDH | CHEK1 | CHEK2 | CHEK2P2 | Chemokine CXC receptor | Chemokine receptor | CHERP | CHFR | CHFR-DT | CHGA | CHGB | CHI3L1